Health system intelligence profile
UCLA / UCLA Health
Editorially verified · Last reviewed August 30, 2026
Intelligence summary
UCLA Technology Development Group is the campus-wide gateway to innovation, research and entrepreneurship at UCLA, including technologies from the David Geffen School of Medicine and UCLA Health. TDG manages invention disclosure, patenting, licensing and startup creation, and negotiates sponsored research and corporate partnership agreements. It runs entrepreneurship programming and connects faculty founders with investors. TDG publishes annual disclosure and company-engagement metrics.
Documented successes: 226 active companies engaged with UCLA technologies; 285 new inventions disclosed in FY2024; notable startups include Cytovale, Inc., ExoZymes, Inc. and Cleopatra Rx
Mandate and remit
UCLA Technology Development Group is the campus-wide gateway to innovation, research and entrepreneurship at UCLA, including technologies from the David Geffen School of Medicine and UCLA Health. TDG manages invention disclosure, patenting, licensing and startup creation, and negotiates sponsored research and corporate partnership agreements. It runs entrepreneurship programming and connects faculty founders with investors. TDG publishes annual disclosure and company-engagement metrics.
These routes appear in the program's sourced public record.
Fund or office: UCLA Technology Development Group (TDG)
UCLA Technology Development Group is the campus-wide gateway to innovation, research and entrepreneurship at UCLA, including technologies from the David Geffen School of Medicine and UCLA Health. TDG manages invention disclosure, patenting, licensing and startup creation, and negotiates sponsored research and corporate partnership agreements. It runs entrepreneurship programming and connects faculty founders with investors. TDG publishes annual disclosure and company-engagement metrics.
Documented successes
226 active companies engaged with UCLA technologies; 285 new inventions disclosed in FY2024; notable startups include Cytovale, Inc., ExoZymes, Inc. and Cleopatra Rx
Organizational home: UCLA Technology Development Group (TDG), UCLA / UCLA Health
Use the program's published contact route for partnership, licensing, innovation, or program inquiries.
Comparable records based on shared public taxonomy, location, or commercialization route.
Same state · Same program type · Same commercialization route
Los Angeles, California
Cedars-Sinai Technology Ventures
Cedars-Sinai Technology Ventures is the health system's publicly described home for intellectual property, venture investment, and startup acceleration.
Academic · Nonprofit
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
Los Angeles, California
West Coast Consortium for Technology and Innovation in Pediatrics (CTIP)
CTIP is an FDA-funded pediatric device consortium led by Children's Hospital Los Angeles that accelerates the development and commercialization of pediatric medical devices from concept to market.
Children's · Nonprofit
Read the intelligence briefPartially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
Duarte, California
Office of Technology Licensing (OTL)
City of Hope's Office of Technology Licensing works with City of Hope inventors to identify, protect and commercialize their inventions and technologies.
Nonprofit
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
Emeryville, California
Inflect Capital
Inflect Capital is the venture-investment offering of Inflect, a healthcare innovation platform backed by the physician-owned and physician-led partnership Vituity.
For profit · National
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
Los Angeles, California
USC Stevens Center for Innovation
The USC Stevens Center for Innovation is the University of Southern California's technology licensing office, serving inventors across the university including the Keck School of Medicine and Keck Medicine of USC clinical enterprise.
Academic · Nonprofit
Read the intelligence briefPartially verified · Reviewed August 30, 2026
Same state · Same program type · Same commercialization route
Stanford, California
Stanford Mussallem Center for Biodesign
Stanford Medicine's Mussallem Center for Biodesign is a named health-technology innovation center with programs that teach a need-driven process for identifying health needs, inventing technologies, and moving solutions toward patient care.
Academic
Read the intelligence briefEditorially verified · Reviewed August 30, 2026
Reviewed August 30, 2026. External source links open in a new tab.
Confidential comparison
Request a confidential conversation about the commercial opportunities, market pathways, and capabilities within your hospital's innovation portfolio. The public directory does not score or rank programs.